Population pharmacokinetics of haloperidol in terminally ill adult patients

PURPOSE: Over 80% of the terminally ill patients experience delirium in their final days. In the treatment of delirium, haloperidol is the drug of choice. Very little is known about the pharmacokinetics of haloperidol in this patient population. We therefore designed a population pharmacokinetic stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Franken, L. G., Mathot, R. A. A., Masman, A. D., Baar, F. P. M., Tibboel, D., van Gelder, T., Koch, B. C. P., de Winter, B. C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599451/
https://www.ncbi.nlm.nih.gov/pubmed/28681176
http://dx.doi.org/10.1007/s00228-017-2283-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599451/
https://www.ncbi.nlm.nih.gov/pubmed/28681176
http://dx.doi.org/10.1007/s00228-017-2283-6

Ejemplares similares